Shots: The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics, metabolomics, and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes, giving doctors the ability to prescribe more precise anti-obesity treatments The study showed that phenotype-specific obesity resulted in nearly double the weight loss over the treatment course of […]Read More
Shots: Abbott has received the US FDA’s EUA for AdviseDx SARS-CoV-2 IgM lab-based serology test for use on the ARCHITECT and Alinity platforms Till now, Abbott has received EUA for its seven tests, including molecular tests, a rapid antigen test and, an IgG Ab test for COVID-19 The IgM test demonstrated 99.56% specificity and 95.00% […]Read More
Shots: The study involved 1402 patients across 3 cohorts: a) 81 patients in Arizona (34 with AD and 47 without), b) 699 in Sweden (301 with no cognitive impairment, 178 with mild cognitive impairment, 121 with AD dementia and 99 with other neurodegenerative diseases) and c) 622 in Colombia (365 with E280A mutations and 257 […]Read More
Shots: Abbott’s SARS-CoV-2 IgG lab-based serology blood test is the fourth COVID-19 detection test to receive the FDA’ EUA based on Alinity i platforms, which is a next-generation immunoassay instrument offering efficiency to lab clinicians for running tests SARS-CoV-2 IgG lab-based serology blood test is a reliable test for customers and patients to detect Abs […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
